Brain Injury Completed Phase 2 Trials for Melatonin (DB01065)

Also known as: Brain Injuries / Brain Damage / Head injury NOS / Cerebral damage / Brain injury NOS

IndicationStatusPhase
DBCOND0028243 (Brain Injury)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00649961Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyOther